Enzyre: towards market leadership in the blood coagulation

Noviotech Campus-based Enzyre, the spin-out from Radboudumc, has a mission: develop ambulatory diagnostic technology for blood clotting tests that allow (haemophilia) patients themselves to gain management of their condition. That mission led to the widely deployable EnzyPad platform technology and plenty of interest from partners and investors. 

In the spring edition of Biotech News, an article about Enzyre was published. Check it out here (in Dutch): https://ap.lc/5rq3h